Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Pediatric Blood & Cancer|October 24, 2020
Clinical utilization of blinatumomab and inotuzumab immunotherapy in children with relapsed or refractory B-acute lymphoblastic leukemiaCristina F Contreras, Christine S Higham, Astrid Behnert, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 14, 2020
Reduced Toxicity Conditioning for Nonmalignant Hematopoietic Cell TransplantsCristina F Contreras, Janel R Long-Boyle, Kristin A Shimano, et al.Cell|March 25, 2021
Genetically engineered myeloid cells rebalance the core immune suppression program in metastasisSabina Kaczanowska, Daniel W Beury, Vishaka Gopalan, et al.Nature Communications|July 2, 2025
Identification of the Notch ligand DLK1 as an immunotherapeutic target and regulator of tumor cell plasticity and chemoresistance in adrenocortical carcinomaNai-Yun Sun, Suresh Kumar, Yoo Sun Kim, et al.Cancer Cell|December 22, 2023
Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapySabina Kaczanowska, Tara Murty, Ahmad Alimadadi, et al.Cancer Discovery|February 10, 2021
Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory, or High-Risk Leukemias: A Report from the LEAP ConsortiumYana Pikman, Sarah K Tasian, Maria Luisa Sulis, et al.Pageof 1